01:04 AM EDT, 10/05/2026 (MT Newswires) -- FluoGuide (FLUO.ST) signed a non-exclusive collaboration agreement with medical technology company Leica Microsystems to advance brain tumor surgery technology. The Sweden-listed precision cancer surgery company said on Oct. 2 that the partnership will optimize the use of Leica's imaging systems, alongside FluoGuide's FG001 technology, to improve the treatment for patients with high-grade glioma. The agreement also focuses on supporting the clinical phase and gathering evidence for Leica's technology platform.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.